Utama › Serangan Jantung › Kansas

Kajian klinikal Serangan Jantung di Kansas

3 kajian untuk Serangan Jantung sedang mencari peserta di lokasi di Kansas.

Teks kajian rasmi (Bahasa Inggeris)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Kansas Nephrology Physicians, PA, Wichita

Mengambil pesertaFasa 2/3

Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05485961

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

University of Kansas Hospital, Kansas City
Cotton O Neil Clinical Res Center, Topeka

Mengambil pesertaFasa 3

Umur 18 hingga 100 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07517263

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

Hutchinson Clinic PA, Hutchinson
University of Kansas Medical Center, Kansas City
Midwest Heart and Vascular Specialists, Overland Park

Mengambil pesertaFasa 3

Umur 50 hingga 105 · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT07136012

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.